REAL-WORLD NON-PERSISTENCE WITH ORAL MULTIPLE MYELOMA TREATMENTS: A COMPARATIVE ANALYSIS OF METHODOLOGIES USING CLAIMS DATA

被引：0
|
作者：
Kocaata, Z. [1 ]
Mueller, S. [2 ]
Maywald, U. [3 ]
Wilke, T. [4 ]
机构：
[1] Ingress Hlth HWM GmbH, Wismar, MV, Germany
[2] Ingress Hlth, Wismar, Germany
[3] AOK PLUS, Dresden, Germany
[4] IPAM eV, Wismar, Germany
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN156
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 50 条
  • [21] Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis
    Chastek, Benjamin
    Carrera, Adam
    Landis, Christina
    Snyder, Daniel
    Abedinzadeh, Laleh
    Bancroft, Tim
    Nesheim, Jeffrey
    Kennelly, Michael
    Staskin, David
    ADVANCES IN THERAPY, 2024, 41 (05) : 2086 - 2097
  • [22] Real-World Adherence and Persistence of Vibegron in Patients With Overactive Bladder: A Retrospective Claims Analysis
    Chastek, B.
    Carrera, A.
    Landis, C.
    Snyder, D.
    Abedinzadeh, L.
    Bancroft, T.
    Nesheim, J.
    Staskin, D.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S199 - S199
  • [23] Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis
    Benjamin Chastek
    Adam Carrera
    Christina Landis
    Daniel Snyder
    Laleh Abedinzadeh
    Tim Bancroft
    Jeffrey Nesheim
    Michael Kennelly
    David Staskin
    Advances in Therapy, 2024, 41 : 2086 - 2097
  • [24] Development and validation of algorithms for identifying lines of therapy in multiple myeloma using real-world data
    Ailawadhi, Sikander
    Romanus, Dorothy
    Shah, Surbhi
    Fraeman, Kathy
    Saragoussi, Delphine
    Buus, Rebecca Morris
    Nguyen, Binh
    Cherepanov, Dasha
    Lamerato, Lois
    Berger, Ariel
    FUTURE ONCOLOGY, 2024, 20 (15) : 981 - 995
  • [25] EFFECT OF DARATUMUMAB ON PNEUMONIA IN PATIENTS WITH MULTIPLE MYELOMA USING POPULATION BASED REAL-WORLD DATA
    Kim, Y.
    Kang, K. W.
    Suh, H. S.
    VALUE IN HEALTH, 2023, 26 (12) : S17 - S17
  • [26] USING REAL-WORLD CLAIMS DATA FOR PLANNING ONCOLOGY CLINICAL TRIALS
    Foley, K. A.
    Hansen, L. G.
    VALUE IN HEALTH, 2013, 16 (03) : A51 - A51
  • [27] Real-world assessment of myelodysplastic syndrome: Japanese claims data analysis
    Tsutsue, Saaya
    Suzuki, Takahiro
    Kim, Hyojin
    Crawford, Bruce
    FUTURE ONCOLOGY, 2021, 18 (01) : 93 - 104
  • [28] A real-world comparative analysis of pomalidomide (POM) and other antimyeloma treatments following lenalidomide (LEN) discontinuation among patients with multiple myeloma.
    Rifkin, Robert M.
    Clancy, Zoe
    Copher, Ronda
    Aguilar, Kathleen M.
    Xie, Yiqiong
    Boyd, Marley
    Wentworth, Chuck
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Real-World Data on Frontline (FL) Treatments in Multiple Myeloma (MM) Patients across EU5 Countries
    Anjo, Joana
    Rider, Alex
    Bailey, Abigail
    Gaudig, Maren
    BLOOD, 2018, 132
  • [30] The outcome of multiple myeloma patients presenting with renal impairment: A real-world data
    A, K. V.
    Narayanan, G.
    Nair, S. G.
    Np, P.
    Thambi, S. M.
    ANNALS OF ONCOLOGY, 2024, 35
12345